John K. Bakewell

John K. Bakewell, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Xtant Medical Holdings, Inc., Treace Medical Concepts, Inc. and Neuronetics, Inc. Between 31 December 2015 and 15 August 2026, the trades on record add up to 16 filings.

Both buying and selling appear: 1 purchase worth €551k, against 1 sale worth €36k. Purchases outweigh sales by €515k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 13 share grants.

The latest filing, published on 18 August 2026, reports a share grant in Xtant Medical Holdings, Inc. The last insider purchase was made public on 13 May 2024, 888 days ago. Typically, a trade is published a median of 3 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.